Literature DB >> 16814284

Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.

Stephanie N Thompson1, Tonya R Gibson, Brian M Thompson, Ying Deng, Edward D Hall.   

Abstract

The role of neuronal plasticity and repair on the final functional outcome following traumatic brain injury (TBI) remains poorly understood. Moreover, the relationship of the magnitude of post-traumatic secondary injury and neurodegeneration to the potential for neuronal repair has not been explored. To address these questions, we employed Western immunoblotting techniques to examine how injury severity affects the spatial and temporal expression of markers of axonal growth (growth-associated protein GAP-43) and synaptogenesis (pre-synaptic vesicular protein synaptophysin) following either moderate (0.5 mm, 3.5 M/s) or severe (1.0 mm, 3.5 M/s) lateral controlled cortical impact traumatic brain injury (CCI-TBI) in young adult male CF-1 mice. Moderate CCI increased GAP-43 levels at 24 and 48 h post-insult in the ipsilateral hippocampus relative to sham, non-injured animals. This increase in axonal plasticity occurred prior to maximal hippocampal neurodegeneration, as revealed by de Olmos silver staining, at 72 h. However, moderate CCI-TBI did not elevate GAP-43 expression in the ipsilateral cortex where neurodegeneration was extensive by 6 h post-TBI. In contrast to moderate injury, severe CCI-TBI failed to increase hippocampal GAP-43 levels and instead resulted in depressed GAP-43 expression in the ipsilateral hippocampus and cortex at 48 h post-insult. In regards to injury-induced changes in synaptogenesis, we found that moderate CCI-TBI elevated synaptophysin levels in the ipsilateral hippocampus at 24, 48, 72 h and 21 days, but this effect was not present after severe injury. Together, these data highlights the adult brain's ability for axonal and synaptic plasticity following a focal cortical injury, but that severe injuries may diminish these endogenous repair mechanisms. The differential effects of moderate versus severe TBI on the post-traumatic plasticity response may be related to the calpain-mediated proteolytic activity occurring after a severe injury preventing increased expression of proteins required for plasticity. Supporting this hypothesis is the fact that GAP-43 is a substrate for calpain along with our data demonstrating that calpain-mediated degradation of the cytoskeletal protein, alpha-spectrin, is approximately 10 times greater in ipsilateral hippocampal tissue following severe compared to moderate CCI-TBI. Thus, TBI severity has a differential effect on the injury-induced neurorestorative response with calpain activation being one putative factor contributing to neuroregenerative failure following severe CCI-TBI. If true, then calpain inhibition may lead to both neuroprotective effects and an enhancement of neuronal plasticity/repair mechanisms post-TBI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814284     DOI: 10.1016/j.expneurol.2006.04.013

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  45 in total

1.  Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury.

Authors:  Patrick G Sullivan; Andrea H Sebastian; Edward D Hall
Journal:  J Neurotrauma       Date:  2011-02-02       Impact factor: 5.269

Review 2.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

3.  A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.

Authors:  Stephanie N Thompson; Kimberly M Carrico; Ayman G Mustafa; Mona Bains; Edward D Hall
Journal:  J Neurotrauma       Date:  2010-12       Impact factor: 5.269

4.  Docosanoids Promote Neurogenesis and Angiogenesis, Blood-Brain Barrier Integrity, Penumbra Protection, and Neurobehavioral Recovery After Experimental Ischemic Stroke.

Authors:  Ludmila Belayev; Sung-Ha Hong; Hemant Menghani; Shawn J Marcell; Andre Obenaus; Raul S Freitas; Larissa Khoutorova; Veronica Balaszczuk; Bokkyoo Jun; Reinaldo B Oriá; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2018-06-01       Impact factor: 5.590

5.  Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.

Authors:  Ayman G Mustafa; Juan A Wang; Kimberly M Carrico; Edward D Hall
Journal:  J Neurochem       Date:  2011-03-22       Impact factor: 5.372

6.  Combining Multiple Types of Motor Rehabilitation Enhances Skilled Forelimb Use Following Experimental Traumatic Brain Injury in Rats.

Authors:  DeAnna L Adkins; Lindsay Ferguson; Steven Lance; Aleksandr Pevtsov; Kevin McDonough; Justin Stamschror; Theresa A Jones; Dorothy A Kozlowski
Journal:  Neurorehabil Neural Repair       Date:  2015-03-11       Impact factor: 3.919

7.  Neonatal Propofol Anesthesia Changes Expression of Synaptic Plasticity Proteins and Increases Stereotypic and Anxyolitic Behavior in Adult Rats.

Authors:  Desanka Milanovic; Vesna Pesic; Natasa Loncarevic-Vasiljkovic; Vladimir Avramovic; Vesna Tesic; Vesna Jevtovic-Todorovic; Selma Kanazir; Sabera Ruzdijic
Journal:  Neurotox Res       Date:  2017-04-24       Impact factor: 3.911

8.  Experimental traumatic brain injury alters ethanol consumption and sensitivity.

Authors:  Jennifer L Lowing; Laura L Susick; James P Caruso; Anthony M Provenzano; Ramesh Raghupathi; Alana C Conti
Journal:  J Neurotrauma       Date:  2014-09-02       Impact factor: 5.269

9.  Temporal dependence of cysteine protease activation following excitotoxic hippocampal injury.

Authors:  J N Berry; L J Sharrett-Field; T R Butler; M A Prendergast
Journal:  Neuroscience       Date:  2012-07-27       Impact factor: 3.590

10.  Dosing and safety of cyclosporine in patients with severe brain injury.

Authors:  Jimmi Hatton; Bonnie Rosbolt; Philip Empey; Richard Kryscio; Byron Young
Journal:  J Neurosurg       Date:  2008-10       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.